| Patient | Dorothea Lange |
|---|---|
| Date of birth | 1895-05-26 |
| Identifiers | MRN HR-ML045-SYN-TD; SSN (made up) 000-45-9127 |
| Document date | 2026-11-01 |
| Author | Gwendolyn Ashford-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for new fatigue, weakness, muscle pain, and falls 55 years after childhood polio; recent heartburn. Concerns: New tiredness and weakness, now in the good leg and the arms as well as the leg weakened by polio in childhood, with aching after work and two falls; Heartburn after meals and at night for three months; Wants to keep photographing in the field and fears having to give it up. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 1956-06-02 | active | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth 30 to 60 minutes before breakfast, an eight-week trial for heartburn | One capsule once daily before breakfast | Oral route | 1957-02-09 to 1957-04-06 | completed | S |
| Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (1931 units) by mouth once daily | Two tablets once daily | Oral route | 1957-02-25 | active | S |
| Calcium carbonate 500 mg chewable tablet, one or two tablets by mouth as needed for heartburn, no more than six tablets a day, while off omeprazole before the endoscopy | One or two tablets up to every 4 hours as needed | Oral route | 1957-04-20 to 1957-05-18 | completed | S |
| Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a year | One infusion once a year | Intravenous route | 1957-04-20 | active | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth before breakfast for eight weeks to heal esophagitis, then the lowest dose that controls symptoms | One capsule once daily before breakfast | Oral route | 1957-05-18 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Nerve conduction studies of both legs and the right arm: normal sensory and motor responses; no neuropathy or entrapment | 1957-02-18 to 1957-02-18 | completed | S |
| Needle electromyography: large, long-duration, polyphasic motor units with reduced recruitment in the right quadriceps, tibialis anterior, and gastrocnemius; milder chronic reinnervation in the left vastus lateralis and right deltoid, muscles not known to have been affected; occasional fibrillation potentials in the right tibialis anterior; no myopathic units and no decrement on repetitive stimulation | 1957-02-18 to 1957-02-18 | completed | S |
| Bone density scan (DXA) of the lumbar spine and both hips, with vertebral fracture assessment: osteoporosis of the right femoral neck; no vertebral fracture | 1957-02-25 to 1957-02-25 | completed | S |
| Seated spirometry: forced vital capacity 2.52 L (92 percent of predicted), FEV1/FVC 78 percent; normal | 1957-02-25 to 1957-02-25 | completed | S |
| Home overnight pulse oximetry: mean oxygen saturation 94 percent, oxygen desaturation index 3 per hour, no sustained desaturation; no nocturnal hypoventilation or sleep apnea pattern | 1957-03-10 to 1957-03-10 | completed | S |
| Outpatient physical therapy, twelve weeks: individualized non-fatiguing strengthening and aerobic training with rest days, warm-water exercise, gait and balance training, and energy conservation | 1957-03-03 to 1957-05-26 | completed | S |
| Custom lightweight carbon-fiber ankle-foot orthosis for the right leg, fitted and adjusted, with a single-point cane for the left hand | 1957-03-24 to 1957-03-24 | completed | S |
| Intravenous infusion of zoledronic acid 5 mg over 30 minutes, after checking calcium, vitamin D, and creatinine; tolerated | 1957-04-20 to 1957-04-20 | completed | S |
| Upper endoscopy with biopsies, three and a half weeks off omeprazole, under moderate sedation at reduced doses with continuous oxygen saturation and carbon dioxide monitoring: Los Angeles grade B esophagitis; 2 cm sliding hiatal hernia; regular squamocolumnar junction with no columnar-lined esophagus (no Barrett's esophagus); stomach with healed changes of the earlier ulcer operation and no ulcer; gastric biopsies without Helicobacter pylori | 1957-05-01 to 1957-05-01 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1956-10-20 | Influenza vaccine, 1956-1957 season | completed | S |
| 1950-04-15 | Tdap vaccine | completed | S |
| 1957-09-28 | Influenza vaccine, 1957-1958 season | completed | S |
| 1957-09-28 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1957-09-28 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1902 | Polio at age seven, leaving a weakened right leg and a lifelong limp | D (CLM-0002) |
| 1945 to 1948 | Severe stomach ulcers controlled by surgery | D (CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| New tiredness and weakness, now in the good leg and the arms as well as the leg weakened by polio in childhood, with aching after work and two falls | active | S |
| Heartburn after meals and at night for three months | active | S |
| Wants to keep photographing in the field and fears having to give it up | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 13.1 on 1957-02-09; Leukocytes [#/volume] in Blood by Automated count 8.6 on 1957-04-22; Platelets [#/volume] in Blood by Automated count 248 on 1957-02-09; Sodium [Moles/volume] in Serum or Plasma 140 on 1957-02-09; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1957-02-09; Creatinine [Mass/volume] in Serum or Plasma 0.8 on 1957-04-22; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M 93 on 1957-04-20; Glucose [Mass/volume] in Serum or Plasma 92 on 1957-02-09; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1957-02-09; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 1957-02-09; Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 228 on 1957-02-09; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 512 on 1957-02-09; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1957-04-20; Calcium [Mass/volume] in Serum or Plasma 8.9 on 1957-04-22; Albumin [Mass/volume] in Serum or Plasma 4.2 on 1957-02-09; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 17 on 1957-02-09; Erythrocyte [Sedimentation Rate] in Blood by Westergren method 12 on 1957-02-09; C reactive protein [Mass/volume] in Serum or Plasma 0.3 on 1957-02-09; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1957-08-17; Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 on 1957-08-17; Parathyrin.intact [Mass/volume] in Serum or Plasma 58 on 1957-02-25; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 82 on 1957-02-25; Phosphate [Mass/volume] in Serum or Plasma 3.4 on 1957-02-25; Magnesium [Mass/volume] in Serum or Plasma 2 on 1957-02-25; Forced vital capacity [Volume] Respiratory system 2.52 on 1957-02-25; FVC measured/predicted 92 on 1957-02-25; FEV1/FVC 78 on 1957-02-25; DXA Lumbar spine [T-score] Bone density -1.8 on 1957-02-25; DXA Femur - right [T-score] Bone density -2.7 on 1957-02-25; DXA Femur - left [T-score] Bone density -1.6 on 1957-02-25; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1957-09-28; Total score [AUDIT-C] 2 on 1957-09-28 [S]
Strengths and supports: Strengths: decades of adapting her work to a weak leg without letting it show; a precise observer who keeps notes; supports: her husband and a photographer colleague who assists in the field [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| New fatigue and slowly increasing weakness for about 18 months, in the left leg and both arms as well as the right leg weakened by polio at seven, with aching muscle pain after work and cold intolerance of the right leg; cause to be established | resolved | confirmed | M62.81 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis of post-polio syndrome at the second visit; the paralytic polio of 1902 is documented (D). |
| Post-polio syndrome (modified March of Dimes criteria met): new weakness of the left quadriceps and both shoulder girdles and increased weakness of the right leg, with fatigue, muscle pain, and cold intolerance, more than 50 years after paralytic polio with partial recovery and decades of stable function; nerve conduction normal; EMG chronic reinnervation in both legs and the right deltoid; other causes excluded | active | confirmed | G14 | S — Synthetic modern diagnosis; the childhood polio is documented (D), and her biographer's account of post-polio symptoms later in life is a retrospective interpretation (R). No neurological finding from her lifetime is used. |
| Heartburn and regurgitation after meals and at night for three months, three to four times a week; no difficulty swallowing, weight loss, vomiting, bleeding, or anemia | resolved | confirmed | R12 | S — Synthetic presenting symptom at the index visit, superseded by the endoscopic diagnosis at the fourth visit. |
| Gastroesophageal reflux disease with Los Angeles grade B erosive esophagitis on upper endoscopy off proton pump inhibitor; no Barrett's esophagus | active | confirmed | K21.00 | S — Synthetic endoscopic diagnosis; it does not echo or foreshadow her later documented illness. |
| Small (2 cm) sliding hiatal hernia on upper endoscopy | active | confirmed | K44.9 | S — Synthetic endoscopic finding. |
| Osteoporosis, worst at the right hip on the polio-weakened side (right femoral neck T-score -2.7; left -1.6; lumbar spine -1.8), with vitamin D insufficiency; no vertebral fracture on assessment; 10-year FRAX risk about 16 percent major osteoporotic and 4.5 percent hip | active | confirmed | M81.8 | S — Synthetic bone density result; disuse of a polio-affected limb lowers bone density on that side. |
| Two falls in the past year without injury, from catching the right foot | active | confirmed | Z91.81 | S — Synthetic fall history at presentation. |
| Surgery for severe stomach ulcers in her early fifties; no ulcer symptoms since; avoids nonsteroidal anti-inflammatory drugs | active | confirmed | Z87.11 | S — Synthetic modern history entry linked to the documented ulcers and surgery of the late 1940s (D); the type of operation is not known. |
| Acute-phase reaction two days after the first zoledronic acid infusion: fever to 38.1 °C, muscle and joint aching, and headache, without signs of infection; calcium normal; resolved in three days with acetaminophen and fluids | resolved | confirmed | T50.995A | S — Synthetic expected adverse effect of a first intravenous bisphosphonate dose. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1957-02-09 | Hemoglobin [Mass/volume] in Blood | 13.1 | g/dL | 12-15.5 g/dL | Normal | S |
| 1957-02-09 | Leukocytes [#/volume] in Blood by Automated count | 6.1 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1957-02-09 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1957-02-09 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 136-145 mmol/L | Normal | S |
| 1957-02-09 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1957-02-09 | Creatinine [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 1957-02-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M | 93 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1957-02-09 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1957-02-09 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 1957-02-09 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1957-02-09 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 228 | U/L | 26-192 U/L | High | S |
| 1957-02-09 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 512 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1957-02-09 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 22 | ng/mL | 30-100 ng/mL | Low | S |
| 1957-02-09 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1957-02-09 | Albumin [Mass/volume] in Serum or Plasma | 4.2 | g/dL | 3.5-5 g/dL | Normal | S |
| 1957-02-09 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 17 | U/L | <=33 U/L | Normal | S |
| 1957-02-09 | Erythrocyte [Sedimentation Rate] in Blood by Westergren method | 12 | mm/h | <=30 mm/h | Normal | S |
| 1957-02-09 | C reactive protein [Mass/volume] in Serum or Plasma | 0.3 | mg/dL | <=0.5 mg/dL | Normal | S |
| 1957-02-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1957-02-09 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 6 | {score} | S | ||
| 1957-02-25 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 58 | pg/mL | 15-65 pg/mL | Normal | S |
| 1957-02-25 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 82 | U/L | 44-147 U/L | Normal | S |
| 1957-02-25 | Phosphate [Mass/volume] in Serum or Plasma | 3.4 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1957-02-25 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.4 mg/dL | Normal | S |
| 1957-02-25 | Forced vital capacity [Volume] Respiratory system | 2.52 | L | >=2.2 L | Normal | S |
| 1957-02-25 | FVC measured/predicted | 92 | % | 80% of predicted or more is normal | Normal | S |
| 1957-02-25 | FEV1/FVC | 78 | % | >=70% | Normal | S |
| 1957-02-25 | DXA Lumbar spine [T-score] Bone density | -1.8 | {T-score} | -2.5 or lower is osteoporosis | Low | S |
| 1957-02-25 | DXA Femur - right [T-score] Bone density | -2.7 | {T-score} | -2.5 or lower is osteoporosis | Low | S |
| 1957-02-25 | DXA Femur - left [T-score] Bone density | -1.6 | {T-score} | -2.5 or lower is osteoporosis | Low | S |
| 1957-04-20 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | 30-100 ng/mL | Normal | S |
| 1957-04-20 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1957-04-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 1957-04-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M | 93 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1957-04-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1957-04-20 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S | ||
| 1957-05-18 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1957-05-18 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 1957-08-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 1957-08-17 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1957-04-22 | Calcium [Mass/volume] in Serum or Plasma | 8.9 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1957-04-22 | Leukocytes [#/volume] in Blood by Automated count | 8.6 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1957-04-22 | Creatinine [Mass/volume] in Serum or Plasma | 0.8 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 1957-09-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1957-09-28 | Total score [AUDIT-C] | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1957-02-09 | Body height | 152 | cm | S |
| 1957-02-09 | Body weight | 50.5 | kg | S |
| 1957-02-09 | Body mass index (BMI) [Ratio] | 21.9 | kg/m2 | S |
| 1957-02-09 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1957-02-09 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1957-02-09 | Heart rate | 76 | /min | S |
| 1957-02-09 | Respiratory rate | 14 | /min | S |
| 1957-02-09 | Body temperature | 36.6 | Cel | S |
| 1957-02-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1957-02-25 | Body height | 152 | cm | S |
| 1957-02-25 | Body weight | 50.3 | kg | S |
| 1957-02-25 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 1957-02-25 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1957-02-25 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1957-02-25 | Heart rate | 74 | /min | S |
| 1957-02-25 | Respiratory rate | 14 | /min | S |
| 1957-02-25 | Body temperature | 36.5 | Cel | S |
| 1957-02-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1957-04-20 | Body height | 152 | cm | S |
| 1957-04-20 | Body weight | 50.6 | kg | S |
| 1957-04-20 | Body mass index (BMI) [Ratio] | 21.9 | kg/m2 | S |
| 1957-04-20 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1957-04-20 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1957-04-20 | Heart rate | 72 | /min | S |
| 1957-04-20 | Respiratory rate | 14 | /min | S |
| 1957-04-20 | Body temperature | 36.6 | Cel | S |
| 1957-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1957-05-18 | Body height | 152 | cm | S |
| 1957-05-18 | Body weight | 50.8 | kg | S |
| 1957-05-18 | Body mass index (BMI) [Ratio] | 22 | kg/m2 | S |
| 1957-05-18 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1957-05-18 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1957-05-18 | Heart rate | 70 | /min | S |
| 1957-05-18 | Respiratory rate | 14 | /min | S |
| 1957-05-18 | Body temperature | 36.6 | Cel | S |
| 1957-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1957-08-17 | Body height | 152 | cm | S |
| 1957-08-17 | Body weight | 51 | kg | S |
| 1957-08-17 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 1957-08-17 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1957-08-17 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1957-08-17 | Heart rate | 72 | /min | S |
| 1957-08-17 | Respiratory rate | 14 | /min | S |
| 1957-08-17 | Body temperature | 36.7 | Cel | S |
| 1957-08-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1957-04-22 | Body height | 152 | cm | S |
| 1957-04-22 | Body weight | 50.2 | kg | S |
| 1957-04-22 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 1957-04-22 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1957-04-22 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1957-04-22 | Heart rate | 92 | /min | S |
| 1957-04-22 | Respiratory rate | 16 | /min | S |
| 1957-04-22 | Body temperature | 38.1 | Cel | S |
| 1957-04-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1957-09-28 | Body height | 152 | cm | S |
| 1957-09-28 | Body weight | 51.2 | kg | S |
| 1957-09-28 | Body mass index (BMI) [Ratio] | 22.2 | kg/m2 | S |
| 1957-09-28 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1957-09-28 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1957-09-28 | Heart rate | 70 | /min | S |
| 1957-09-28 | Respiratory rate | 14 | /min | S |
| 1957-09-28 | Body temperature | 36.6 | Cel | S |
| 1957-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1957-02-09 | Primary care visit for new fatigue, weakness, muscle pain, and falls 55 years after childhood polio; recent heartburn | finished | S |
| 1957-02-25 | Diagnosis of post-polio syndrome with the neuromuscular rehabilitation consultation the same day; bone density and spirometry | finished | S |
| 1957-04-20 | Review after eight weeks of pacing and physical therapy; first zoledronic acid infusion; planning endoscopy after heartburn returned off omeprazole | finished | S |
| 1957-05-18 | Endoscopy results and reflux treatment; post-polio syndrome follow-up | finished | S |
| 1957-08-17 | Six-month review of post-polio syndrome, falls, bone health, and reflux step-down | finished | S |
| 1957-04-22 | Same-day sick visit for fever and aching after zoledronic acid | finished | S |
| 1957-09-28 | Adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Work-up of new weakness as a diagnosis of exclusion: blood count, chemistry, glucose and HbA1c, TSH, B12, vitamin D, calcium, creatine kinase, ESR and CRP today; nerve conduction studies and needle EMG; PHQ-9; sleep screen | completed | GL-MOD-PPS-2001, GL-EFNS-PPS-2006 | S |
| Neuromuscular physical medicine and rehabilitation consultation, to confirm or exclude post-polio syndrome and plan exercise, orthoses, and work adaptations | completed | GL-EFNS-PPS-2006 | S |
| Heartburn: lifestyle measures and an eight-week trial of omeprazole 20 mg before breakfast; endoscopy if alarm features appear or if symptoms return when it is stopped | completed | GL-ACG-GERD-2022 | S |
| Fall prevention: home hazard review, footwear, night lighting, rails on the garden path, and a bone density scan for a woman with a weakened limb and falls | completed | GL-FALLS-2022, GL-CMID-2026 | S |
| Pain care: acetaminophen as needed, heat, pacing, and stretching; no nonsteroidal anti-inflammatory drugs after her ulcer surgery | completed | GL-EFNS-PPS-2006 | S |
| Energy conservation and pacing: plan field days with rest breaks, a lighter camera and a harness instead of a shoulder bag, a seat stick, an assistant to carry the tripod, and a rest day after each field day; stop activity before fatigue | completed | GL-EFNS-PPS-2006 | S |
| Supervised non-fatiguing exercise for twelve weeks (strengthening at submaximal effort with rest days, aerobic training, warm-water exercise, gait and balance training), then a home program | completed | GL-EFNS-PPS-2006 | S |
| Custom lightweight carbon-fiber ankle-foot orthosis for right foot drop and knee instability, and a cane in the left hand; reassess for a knee-ankle-foot orthosis if knee buckling continues | completed | GL-EFNS-PPS-2006 | S |
| Respiratory and sleep assessment: baseline spirometry and home overnight oximetry, with yearly spirometry and earlier review for breathlessness, morning headache, or swallowing trouble | completed | GL-EFNS-PPS-2006 | S |
| Osteoporosis: vitamin D3 1931 units daily and dietary calcium; zoledronic acid 5 mg yearly once vitamin D is replete, given intravenously because of active reflux symptoms; DXA in two years; secondary-causes tests including a 24-hour urine calcium | completed | GL-CMID-2026, GL-AACE-OP-2020, GL-FDA-ZOL-2026 | S |
| Sedation and anesthesia precautions for post-polio syndrome recorded in the chart: reduced sedative and opioid doses, continuous oxygen and carbon dioxide monitoring, keep warm, careful positioning of the weak leg, and caution with neuromuscular blocking drugs | completed | GL-ANES-PPS-2025, GL-ANES-PPS-2005 | S |
| Upper endoscopy after two to four weeks off omeprazole, because heartburn returned within days of stopping it, with an antacid as needed meanwhile; sedation precautions for post-polio syndrome | completed | GL-ACG-GERD-2022, GL-ANES-PPS-2025 | S |
| Grade B reflux esophagitis: omeprazole 20 mg daily for eight weeks, then step down to the lowest dose that controls symptoms; weight-neutral lifestyle measures, no meals within three hours of bed, head of the bed raised; no Barrett's surveillance after a negative examination | completed | GL-ACG-GERD-2022, GL-ACG-BE-2022 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Find the cause of the new weakness and fatigue within four weeks, with other treatable causes excluded | 1957-02-25 | completed | Post-polio syndrome diagnosed at 16 days after the tests excluded thyroid disease, anemia, diabetes, B12 deficiency, neuropathy, and myopathy | S |
| No falls over the next six months | 1957-08-17 | completed | No falls since the orthosis and cane; Timed Up and Go 11.2 seconds | S |
| Keep working in the field at least two days a week, with planned rests, without exhaustion the next day | 1957-12-31 | active | Working two field days a week with a lighter camera, a seat stick, and rest breaks | S |
| Establish the cause of the heartburn and control it on the lowest effective therapy | 1957-05-18 | completed | Endoscopy showed grade B esophagitis without Barrett's esophagus; omeprazole restarted, symptoms controlled | S |
| Replete vitamin D and start fracture-protective treatment | 1957-04-20 | completed | Vitamin D 34 ng/mL; first zoledronic acid infusion given | S |